SCHEMBL5698111

SCHEMBL5698111

OCc1cc2cccccc-2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.60
PRKCI P41743 1/20 0.54
ACMSD Q8TDX5 1/20 0.48
BACE1 P56817 1/20 0.48
AGXT P21549 1/20 0.45
CNR2 P34972 1/20 0.44
LTA4H P09960 1/20 0.44
ACHE P22303 1/20 0.43
ALOX5 P09917 2/20 0.42
ALDH1A1 P00352 2/20 0.42
NOTUM Q6P988 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
IDH1 O75874 1/20 0.41
TTR P02766 1/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
GRIN1 Q05586 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12294066 0.90 TSHR (0.55) TSHRPRKCIACMSDBACE1AGXT
SCHEMBL21973519 0.90 TSHR (0.55) TSHRPRKCIACMSDBACE1AGXT
SCHEMBL249824 0.87 PRKCI (0.70) TSHRPRKCIACMSDAGXTCNR2
SCHEMBL30108284 0.87 PRKCI (0.70) TSHRPRKCIACMSDAGXTCNR2
SCHEMBL4191589 0.83 PRKCI (0.72) TSHRPRKCIACMSDAGXTCNR2
SCHEMBL23750160 0.82 PRKCI (0.63) TSHRPRKCIACMSDAGXTCNR2
SCHEMBL18297788 0.81 PRKCI (0.76) TSHRPRKCIACMSDAGXTCNR2
SCHEMBL18586418 0.80 FFAR4 (0.50) TSHRPRKCICNR2ALDH1A1GRIN2D
SCHEMBL17954220 0.80 RXRA (0.55) TSHRPRKCIACMSDBACE1CNR2
SCHEMBL3786783 0.80 MAOA (0.48) TSHRPRKCIACMSDBACE1AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1546134-A1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES ELI LILLY AND COMPANY (US) 2005-06-29 EP claimed
WO-2004014895-A1 PIPERAZINE SUBSTITUTED ARYL BENZODIAZEPINES ELI LILLY AND COMPANY (US) 2004-02-19 WO claimed
EP-1684746-A1 USE OF 1-AZA-DIBENZO[e,h]|AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS PLIVA-ISTRAZIVACKI INSTITUT d.o.o. (HR) 2006-08-02 EP disclosed
WO-2005049011-A1 USE OF 1-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-06-02 WO disclosed